Global In-Vitro Diagnostics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report? we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for In-Vitro Diagnostics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of In-Vitro Diagnostics, also provides the value of main regions and countries. Of the upcoming market potential for In-Vitro Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In-Vitro Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global In-Vitro Diagnostics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
In-Vitro Diagnostics segment by Company
1. To analyze and research the global In-Vitro Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the In-Vitro Diagnostics key companies, revenue, market share, and recent developments.
3. To split the In-Vitro Diagnostics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions In-Vitro Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify In-Vitro Diagnostics significant trends, drivers, influence factors in global and regions.
6. To analyze In-Vitro Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In-Vitro Diagnostics industry.
Chapter 3: Detailed analysis of In-Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of In-Vitro Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of In-Vitro Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report? we counted In-Vitro Diagnostics reagent.
According to APO Research, The global In-Vitro Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for In-Vitro Diagnostics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for In-Vitro Diagnostics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of In-Vitro Diagnostics, also provides the value of main regions and countries. Of the upcoming market potential for In-Vitro Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the In-Vitro Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global In-Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global In-Vitro Diagnostics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
In-Vitro Diagnostics segment by Company
- Roche
- Siemens
- Abbott
- Danaher
- Thermo Fisher
- BioMerieux
- Bio-Rad
- BD
- JNJ
- Sysmex
- KHB
- DaAn Gene
- Leadman
- BioSino
- BSBE
- Maccura
- Tissue Diagnostics
- Professional Diagnostic
- Molecular Diagnostic
- Diabetes Monitoring
- Other
- Diabetes
- Infectious Diseases
- Oncology
- Cardiology
- HIV
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global In-Vitro Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the In-Vitro Diagnostics key companies, revenue, market share, and recent developments.
3. To split the In-Vitro Diagnostics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions In-Vitro Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify In-Vitro Diagnostics significant trends, drivers, influence factors in global and regions.
6. To analyze In-Vitro Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In-Vitro Diagnostics industry.
Chapter 3: Detailed analysis of In-Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of In-Vitro Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of In-Vitro Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global In-Vitro Diagnostics Market Size, 2019 VS 2023 VS 2030
1.3 Global In-Vitro Diagnostics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 IN-VITRO DIAGNOSTICS MARKET DYNAMICS
2.1 In-Vitro Diagnostics Industry Trends
2.2 In-Vitro Diagnostics Industry Drivers
2.3 In-Vitro Diagnostics Industry Opportunities and Challenges
2.4 In-Vitro Diagnostics Industry Restraints
3 IN-VITRO DIAGNOSTICS MARKET BY COMPANY
3.1 Global In-Vitro Diagnostics Company Revenue Ranking in 2023
3.2 Global In-Vitro Diagnostics Revenue by Company (2019-2024)
3.3 Global In-Vitro Diagnostics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global In-Vitro Diagnostics Company Manufacturing Base & Headquarters
3.5 Global In-Vitro Diagnostics Company, Product Type & Application
3.6 Global In-Vitro Diagnostics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global In-Vitro Diagnostics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 In-Vitro Diagnostics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 IN-VITRO DIAGNOSTICS MARKET BY TYPE
4.1 In-Vitro Diagnostics Type Introduction
4.1.1 Tissue Diagnostics
4.1.2 Professional Diagnostic
4.1.3 Molecular Diagnostic
4.1.4 Diabetes Monitoring
4.1.5 Other
4.2 Global In-Vitro Diagnostics Sales Value by Type
4.2.1 Global In-Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global In-Vitro Diagnostics Sales Value by Type (2019-2030)
4.2.3 Global In-Vitro Diagnostics Sales Value Share by Type (2019-2030)
5 IN-VITRO DIAGNOSTICS MARKET BY APPLICATION
5.1 In-Vitro Diagnostics Application Introduction
5.1.1 Diabetes
5.1.2 Infectious Diseases
5.1.3 Oncology
5.1.4 Cardiology
5.1.5 HIV
5.1.6 Other
5.2 Global In-Vitro Diagnostics Sales Value by Application
5.2.1 Global In-Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global In-Vitro Diagnostics Sales Value by Application (2019-2030)
5.2.3 Global In-Vitro Diagnostics Sales Value Share by Application (2019-2030)
6 IN-VITRO DIAGNOSTICS MARKET BY REGION
6.1 Global In-Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global In-Vitro Diagnostics Sales Value by Region (2019-2030)
6.2.1 Global In-Vitro Diagnostics Sales Value by Region: 2019-2024
6.2.2 Global In-Vitro Diagnostics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America In-Vitro Diagnostics Sales Value (2019-2030)
6.3.2 North America In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe In-Vitro Diagnostics Sales Value (2019-2030)
6.4.2 Europe In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific In-Vitro Diagnostics Sales Value (2019-2030)
6.5.2 Asia-Pacific In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America In-Vitro Diagnostics Sales Value (2019-2030)
6.6.2 Latin America In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa In-Vitro Diagnostics Sales Value (2019-2030)
6.7.2 Middle East & Africa In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
7 IN-VITRO DIAGNOSTICS MARKET BY COUNTRY
7.1 Global In-Vitro Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global In-Vitro Diagnostics Sales Value by Country (2019-2030)
7.2.1 Global In-Vitro Diagnostics Sales Value by Country (2019-2024)
7.2.2 Global In-Vitro Diagnostics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.3.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.4.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.5.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.6.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.7.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.8.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.9.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.10.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.11.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.12.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.13.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.14.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.15.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.16.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.17.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.18.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.19.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.20.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.21.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.1.4 Roche In-Vitro Diagnostics Product Portfolio
8.1.5 Roche Recent Developments
8.2 Siemens
8.2.1 Siemens Comapny Information
8.2.2 Siemens Business Overview
8.2.3 Siemens In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.2.4 Siemens In-Vitro Diagnostics Product Portfolio
8.2.5 Siemens Recent Developments
8.3 Abbott
8.3.1 Abbott Comapny Information
8.3.2 Abbott Business Overview
8.3.3 Abbott In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.3.4 Abbott In-Vitro Diagnostics Product Portfolio
8.3.5 Abbott Recent Developments
8.4 Danaher
8.4.1 Danaher Comapny Information
8.4.2 Danaher Business Overview
8.4.3 Danaher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.4.4 Danaher In-Vitro Diagnostics Product Portfolio
8.4.5 Danaher Recent Developments
8.5 Thermo Fisher
8.5.1 Thermo Fisher Comapny Information
8.5.2 Thermo Fisher Business Overview
8.5.3 Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
8.5.5 Thermo Fisher Recent Developments
8.6 BioMerieux
8.6.1 BioMerieux Comapny Information
8.6.2 BioMerieux Business Overview
8.6.3 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
8.6.5 BioMerieux Recent Developments
8.7 Bio-Rad
8.7.1 Bio-Rad Comapny Information
8.7.2 Bio-Rad Business Overview
8.7.3 Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
8.7.5 Bio-Rad Recent Developments
8.8 BD
8.8.1 BD Comapny Information
8.8.2 BD Business Overview
8.8.3 BD In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.8.4 BD In-Vitro Diagnostics Product Portfolio
8.8.5 BD Recent Developments
8.9 JNJ
8.9.1 JNJ Comapny Information
8.9.2 JNJ Business Overview
8.9.3 JNJ In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.9.4 JNJ In-Vitro Diagnostics Product Portfolio
8.9.5 JNJ Recent Developments
8.10 Sysmex
8.10.1 Sysmex Comapny Information
8.10.2 Sysmex Business Overview
8.10.3 Sysmex In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
8.10.5 Sysmex Recent Developments
8.11 KHB
8.11.1 KHB Comapny Information
8.11.2 KHB Business Overview
8.11.3 KHB In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.11.4 KHB In-Vitro Diagnostics Product Portfolio
8.11.5 KHB Recent Developments
8.12 DaAn Gene
8.12.1 DaAn Gene Comapny Information
8.12.2 DaAn Gene Business Overview
8.12.3 DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
8.12.5 DaAn Gene Recent Developments
8.13 Leadman
8.13.1 Leadman Comapny Information
8.13.2 Leadman Business Overview
8.13.3 Leadman In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.13.4 Leadman In-Vitro Diagnostics Product Portfolio
8.13.5 Leadman Recent Developments
8.14 BioSino
8.14.1 BioSino Comapny Information
8.14.2 BioSino Business Overview
8.14.3 BioSino In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.14.4 BioSino In-Vitro Diagnostics Product Portfolio
8.14.5 BioSino Recent Developments
8.15 BSBE
8.15.1 BSBE Comapny Information
8.15.2 BSBE Business Overview
8.15.3 BSBE In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.15.4 BSBE In-Vitro Diagnostics Product Portfolio
8.15.5 BSBE Recent Developments
8.16 Maccura
8.16.1 Maccura Comapny Information
8.16.2 Maccura Business Overview
8.16.3 Maccura In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.16.4 Maccura In-Vitro Diagnostics Product Portfolio
8.16.5 Maccura Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global In-Vitro Diagnostics Market Size, 2019 VS 2023 VS 2030
1.3 Global In-Vitro Diagnostics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 IN-VITRO DIAGNOSTICS MARKET DYNAMICS
2.1 In-Vitro Diagnostics Industry Trends
2.2 In-Vitro Diagnostics Industry Drivers
2.3 In-Vitro Diagnostics Industry Opportunities and Challenges
2.4 In-Vitro Diagnostics Industry Restraints
3 IN-VITRO DIAGNOSTICS MARKET BY COMPANY
3.1 Global In-Vitro Diagnostics Company Revenue Ranking in 2023
3.2 Global In-Vitro Diagnostics Revenue by Company (2019-2024)
3.3 Global In-Vitro Diagnostics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global In-Vitro Diagnostics Company Manufacturing Base & Headquarters
3.5 Global In-Vitro Diagnostics Company, Product Type & Application
3.6 Global In-Vitro Diagnostics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global In-Vitro Diagnostics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 In-Vitro Diagnostics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 IN-VITRO DIAGNOSTICS MARKET BY TYPE
4.1 In-Vitro Diagnostics Type Introduction
4.1.1 Tissue Diagnostics
4.1.2 Professional Diagnostic
4.1.3 Molecular Diagnostic
4.1.4 Diabetes Monitoring
4.1.5 Other
4.2 Global In-Vitro Diagnostics Sales Value by Type
4.2.1 Global In-Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global In-Vitro Diagnostics Sales Value by Type (2019-2030)
4.2.3 Global In-Vitro Diagnostics Sales Value Share by Type (2019-2030)
5 IN-VITRO DIAGNOSTICS MARKET BY APPLICATION
5.1 In-Vitro Diagnostics Application Introduction
5.1.1 Diabetes
5.1.2 Infectious Diseases
5.1.3 Oncology
5.1.4 Cardiology
5.1.5 HIV
5.1.6 Other
5.2 Global In-Vitro Diagnostics Sales Value by Application
5.2.1 Global In-Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global In-Vitro Diagnostics Sales Value by Application (2019-2030)
5.2.3 Global In-Vitro Diagnostics Sales Value Share by Application (2019-2030)
6 IN-VITRO DIAGNOSTICS MARKET BY REGION
6.1 Global In-Vitro Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global In-Vitro Diagnostics Sales Value by Region (2019-2030)
6.2.1 Global In-Vitro Diagnostics Sales Value by Region: 2019-2024
6.2.2 Global In-Vitro Diagnostics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America In-Vitro Diagnostics Sales Value (2019-2030)
6.3.2 North America In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe In-Vitro Diagnostics Sales Value (2019-2030)
6.4.2 Europe In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific In-Vitro Diagnostics Sales Value (2019-2030)
6.5.2 Asia-Pacific In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America In-Vitro Diagnostics Sales Value (2019-2030)
6.6.2 Latin America In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa In-Vitro Diagnostics Sales Value (2019-2030)
6.7.2 Middle East & Africa In-Vitro Diagnostics Sales Value Share by Country, 2023 VS 2030
7 IN-VITRO DIAGNOSTICS MARKET BY COUNTRY
7.1 Global In-Vitro Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global In-Vitro Diagnostics Sales Value by Country (2019-2030)
7.2.1 Global In-Vitro Diagnostics Sales Value by Country (2019-2024)
7.2.2 Global In-Vitro Diagnostics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.3.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.4.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.5.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.6.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.7.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.8.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.9.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.10.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.11.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.12.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.13.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.14.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.15.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.16.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.17.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.18.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.19.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.20.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global In-Vitro Diagnostics Sales Value Growth Rate (2019-2030)
7.21.2 Global In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.1.4 Roche In-Vitro Diagnostics Product Portfolio
8.1.5 Roche Recent Developments
8.2 Siemens
8.2.1 Siemens Comapny Information
8.2.2 Siemens Business Overview
8.2.3 Siemens In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.2.4 Siemens In-Vitro Diagnostics Product Portfolio
8.2.5 Siemens Recent Developments
8.3 Abbott
8.3.1 Abbott Comapny Information
8.3.2 Abbott Business Overview
8.3.3 Abbott In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.3.4 Abbott In-Vitro Diagnostics Product Portfolio
8.3.5 Abbott Recent Developments
8.4 Danaher
8.4.1 Danaher Comapny Information
8.4.2 Danaher Business Overview
8.4.3 Danaher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.4.4 Danaher In-Vitro Diagnostics Product Portfolio
8.4.5 Danaher Recent Developments
8.5 Thermo Fisher
8.5.1 Thermo Fisher Comapny Information
8.5.2 Thermo Fisher Business Overview
8.5.3 Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
8.5.5 Thermo Fisher Recent Developments
8.6 BioMerieux
8.6.1 BioMerieux Comapny Information
8.6.2 BioMerieux Business Overview
8.6.3 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
8.6.5 BioMerieux Recent Developments
8.7 Bio-Rad
8.7.1 Bio-Rad Comapny Information
8.7.2 Bio-Rad Business Overview
8.7.3 Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
8.7.5 Bio-Rad Recent Developments
8.8 BD
8.8.1 BD Comapny Information
8.8.2 BD Business Overview
8.8.3 BD In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.8.4 BD In-Vitro Diagnostics Product Portfolio
8.8.5 BD Recent Developments
8.9 JNJ
8.9.1 JNJ Comapny Information
8.9.2 JNJ Business Overview
8.9.3 JNJ In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.9.4 JNJ In-Vitro Diagnostics Product Portfolio
8.9.5 JNJ Recent Developments
8.10 Sysmex
8.10.1 Sysmex Comapny Information
8.10.2 Sysmex Business Overview
8.10.3 Sysmex In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
8.10.5 Sysmex Recent Developments
8.11 KHB
8.11.1 KHB Comapny Information
8.11.2 KHB Business Overview
8.11.3 KHB In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.11.4 KHB In-Vitro Diagnostics Product Portfolio
8.11.5 KHB Recent Developments
8.12 DaAn Gene
8.12.1 DaAn Gene Comapny Information
8.12.2 DaAn Gene Business Overview
8.12.3 DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
8.12.5 DaAn Gene Recent Developments
8.13 Leadman
8.13.1 Leadman Comapny Information
8.13.2 Leadman Business Overview
8.13.3 Leadman In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.13.4 Leadman In-Vitro Diagnostics Product Portfolio
8.13.5 Leadman Recent Developments
8.14 BioSino
8.14.1 BioSino Comapny Information
8.14.2 BioSino Business Overview
8.14.3 BioSino In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.14.4 BioSino In-Vitro Diagnostics Product Portfolio
8.14.5 BioSino Recent Developments
8.15 BSBE
8.15.1 BSBE Comapny Information
8.15.2 BSBE Business Overview
8.15.3 BSBE In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.15.4 BSBE In-Vitro Diagnostics Product Portfolio
8.15.5 BSBE Recent Developments
8.16 Maccura
8.16.1 Maccura Comapny Information
8.16.2 Maccura Business Overview
8.16.3 Maccura In-Vitro Diagnostics Revenue and Gross Margin (2019-2024)
8.16.4 Maccura In-Vitro Diagnostics Product Portfolio
8.16.5 Maccura Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. In-Vitro Diagnostics Industry Trends
Table 2. In-Vitro Diagnostics Industry Drivers
Table 3. In-Vitro Diagnostics Industry Opportunities and Challenges
Table 4. In-Vitro Diagnostics Industry Restraints
Table 5. Global In-Vitro Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global In-Vitro Diagnostics Revenue Share by Company (2019-2024)
Table 7. Global In-Vitro Diagnostics Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global In-Vitro Diagnostics Key Company Manufacturing Base & Headquarters
Table 9. Global In-Vitro Diagnostics Company, Product Type & Application
Table 10. Global In-Vitro Diagnostics Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Tissue Diagnostics
Table 15. Major Companies of Professional Diagnostic
Table 16. Major Companies of Molecular Diagnostic
Table 17. Major Companies of Diabetes Monitoring
Table 18. Major Companies of Other
Table 19. Global In-Vitro Diagnostics Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 20. Global In-Vitro Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 21. Global In-Vitro Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 22. Global In-Vitro Diagnostics Sales Value Share by Type (2019-2024)
Table 23. Global In-Vitro Diagnostics Sales Value Share by Type (2025-2030)
Table 24. Major Companies of Diabetes
Table 25. Major Companies of Infectious Diseases
Table 26. Major Companies of Oncology
Table 27. Major Companies of Cardiology
Table 28. Major Companies of HIV
Table 29. Major Companies of Other
Table 30. Global In-Vitro Diagnostics Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global In-Vitro Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 32. Global In-Vitro Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 33. Global In-Vitro Diagnostics Sales Value Share by Application (2019-2024)
Table 34. Global In-Vitro Diagnostics Sales Value Share by Application (2025-2030)
Table 35. Global In-Vitro Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global In-Vitro Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 37. Global In-Vitro Diagnostics Sales Value Share by Region (2019-2024)
Table 38. Global In-Vitro Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 39. Global In-Vitro Diagnostics Sales Value Share by Region (2025-2030)
Table 40. Global In-Vitro Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global In-Vitro Diagnostics Sales Value by Country (2019-2024) & (US$ Million)
Table 42. Global In-Vitro Diagnostics Sales Value Market Share by Country (2019-2024)
Table 43. Global In-Vitro Diagnostics Sales Value by Country (2025-2030) & (US$ Million)
Table 44. Global In-Vitro Diagnostics Sales Value Market Share by Country (2025-2030)
Table 45. Roche Company Information
Table 46. Roche Business Overview
Table 47. Roche In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 48. Roche In-Vitro Diagnostics Product Portfolio
Table 49. Roche Recent Development
Table 50. Siemens Company Information
Table 51. Siemens Business Overview
Table 52. Siemens In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 53. Siemens In-Vitro Diagnostics Product Portfolio
Table 54. Siemens Recent Development
Table 55. Abbott Company Information
Table 56. Abbott Business Overview
Table 57. Abbott In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 58. Abbott In-Vitro Diagnostics Product Portfolio
Table 59. Abbott Recent Development
Table 60. Danaher Company Information
Table 61. Danaher Business Overview
Table 62. Danaher In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 63. Danaher In-Vitro Diagnostics Product Portfolio
Table 64. Danaher Recent Development
Table 65. Thermo Fisher Company Information
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Thermo Fisher In-Vitro Diagnostics Product Portfolio
Table 69. Thermo Fisher Recent Development
Table 70. BioMerieux Company Information
Table 71. BioMerieux Business Overview
Table 72. BioMerieux In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. BioMerieux In-Vitro Diagnostics Product Portfolio
Table 74. BioMerieux Recent Development
Table 75. Bio-Rad Company Information
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Bio-Rad In-Vitro Diagnostics Product Portfolio
Table 79. Bio-Rad Recent Development
Table 80. BD Company Information
Table 81. BD Business Overview
Table 82. BD In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. BD In-Vitro Diagnostics Product Portfolio
Table 84. BD Recent Development
Table 85. JNJ Company Information
Table 86. JNJ Business Overview
Table 87. JNJ In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. JNJ In-Vitro Diagnostics Product Portfolio
Table 89. JNJ Recent Development
Table 90. Sysmex Company Information
Table 91. Sysmex Business Overview
Table 92. Sysmex In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. Sysmex In-Vitro Diagnostics Product Portfolio
Table 94. Sysmex Recent Development
Table 95. KHB Company Information
Table 96. KHB Business Overview
Table 97. KHB In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. KHB In-Vitro Diagnostics Product Portfolio
Table 99. KHB Recent Development
Table 100. DaAn Gene Company Information
Table 101. DaAn Gene Business Overview
Table 102. DaAn Gene In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. DaAn Gene In-Vitro Diagnostics Product Portfolio
Table 104. DaAn Gene Recent Development
Table 105. Leadman Company Information
Table 106. Leadman Business Overview
Table 107. Leadman In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Leadman In-Vitro Diagnostics Product Portfolio
Table 109. Leadman Recent Development
Table 110. BioSino Company Information
Table 111. BioSino Business Overview
Table 112. BioSino In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. BioSino In-Vitro Diagnostics Product Portfolio
Table 114. BioSino Recent Development
Table 115. BSBE Company Information
Table 116. BSBE Business Overview
Table 117. BSBE In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BSBE In-Vitro Diagnostics Product Portfolio
Table 119. BSBE Recent Development
Table 120. Maccura Company Information
Table 121. Maccura Business Overview
Table 122. Maccura In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Maccura In-Vitro Diagnostics Product Portfolio
Table 124. Maccura Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Authors List of This Report
Table 127. Secondary Sources
Table 128. Primary Sources
Table 1. In-Vitro Diagnostics Industry Trends
Table 2. In-Vitro Diagnostics Industry Drivers
Table 3. In-Vitro Diagnostics Industry Opportunities and Challenges
Table 4. In-Vitro Diagnostics Industry Restraints
Table 5. Global In-Vitro Diagnostics Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global In-Vitro Diagnostics Revenue Share by Company (2019-2024)
Table 7. Global In-Vitro Diagnostics Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global In-Vitro Diagnostics Key Company Manufacturing Base & Headquarters
Table 9. Global In-Vitro Diagnostics Company, Product Type & Application
Table 10. Global In-Vitro Diagnostics Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Tissue Diagnostics
Table 15. Major Companies of Professional Diagnostic
Table 16. Major Companies of Molecular Diagnostic
Table 17. Major Companies of Diabetes Monitoring
Table 18. Major Companies of Other
Table 19. Global In-Vitro Diagnostics Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 20. Global In-Vitro Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
Table 21. Global In-Vitro Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
Table 22. Global In-Vitro Diagnostics Sales Value Share by Type (2019-2024)
Table 23. Global In-Vitro Diagnostics Sales Value Share by Type (2025-2030)
Table 24. Major Companies of Diabetes
Table 25. Major Companies of Infectious Diseases
Table 26. Major Companies of Oncology
Table 27. Major Companies of Cardiology
Table 28. Major Companies of HIV
Table 29. Major Companies of Other
Table 30. Global In-Vitro Diagnostics Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global In-Vitro Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
Table 32. Global In-Vitro Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
Table 33. Global In-Vitro Diagnostics Sales Value Share by Application (2019-2024)
Table 34. Global In-Vitro Diagnostics Sales Value Share by Application (2025-2030)
Table 35. Global In-Vitro Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Global In-Vitro Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
Table 37. Global In-Vitro Diagnostics Sales Value Share by Region (2019-2024)
Table 38. Global In-Vitro Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
Table 39. Global In-Vitro Diagnostics Sales Value Share by Region (2025-2030)
Table 40. Global In-Vitro Diagnostics Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global In-Vitro Diagnostics Sales Value by Country (2019-2024) & (US$ Million)
Table 42. Global In-Vitro Diagnostics Sales Value Market Share by Country (2019-2024)
Table 43. Global In-Vitro Diagnostics Sales Value by Country (2025-2030) & (US$ Million)
Table 44. Global In-Vitro Diagnostics Sales Value Market Share by Country (2025-2030)
Table 45. Roche Company Information
Table 46. Roche Business Overview
Table 47. Roche In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 48. Roche In-Vitro Diagnostics Product Portfolio
Table 49. Roche Recent Development
Table 50. Siemens Company Information
Table 51. Siemens Business Overview
Table 52. Siemens In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 53. Siemens In-Vitro Diagnostics Product Portfolio
Table 54. Siemens Recent Development
Table 55. Abbott Company Information
Table 56. Abbott Business Overview
Table 57. Abbott In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 58. Abbott In-Vitro Diagnostics Product Portfolio
Table 59. Abbott Recent Development
Table 60. Danaher Company Information
Table 61. Danaher Business Overview
Table 62. Danaher In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 63. Danaher In-Vitro Diagnostics Product Portfolio
Table 64. Danaher Recent Development
Table 65. Thermo Fisher Company Information
Table 66. Thermo Fisher Business Overview
Table 67. Thermo Fisher In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 68. Thermo Fisher In-Vitro Diagnostics Product Portfolio
Table 69. Thermo Fisher Recent Development
Table 70. BioMerieux Company Information
Table 71. BioMerieux Business Overview
Table 72. BioMerieux In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 73. BioMerieux In-Vitro Diagnostics Product Portfolio
Table 74. BioMerieux Recent Development
Table 75. Bio-Rad Company Information
Table 76. Bio-Rad Business Overview
Table 77. Bio-Rad In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 78. Bio-Rad In-Vitro Diagnostics Product Portfolio
Table 79. Bio-Rad Recent Development
Table 80. BD Company Information
Table 81. BD Business Overview
Table 82. BD In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 83. BD In-Vitro Diagnostics Product Portfolio
Table 84. BD Recent Development
Table 85. JNJ Company Information
Table 86. JNJ Business Overview
Table 87. JNJ In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 88. JNJ In-Vitro Diagnostics Product Portfolio
Table 89. JNJ Recent Development
Table 90. Sysmex Company Information
Table 91. Sysmex Business Overview
Table 92. Sysmex In-Vitro Diagnostics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 93. Sysmex In-Vitro Diagnostics Product Portfolio
Table 94. Sysmex Recent Development
Table 95. KHB Company Information
Table 96. KHB Business Overview
Table 97. KHB In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. KHB In-Vitro Diagnostics Product Portfolio
Table 99. KHB Recent Development
Table 100. DaAn Gene Company Information
Table 101. DaAn Gene Business Overview
Table 102. DaAn Gene In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. DaAn Gene In-Vitro Diagnostics Product Portfolio
Table 104. DaAn Gene Recent Development
Table 105. Leadman Company Information
Table 106. Leadman Business Overview
Table 107. Leadman In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Leadman In-Vitro Diagnostics Product Portfolio
Table 109. Leadman Recent Development
Table 110. BioSino Company Information
Table 111. BioSino Business Overview
Table 112. BioSino In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. BioSino In-Vitro Diagnostics Product Portfolio
Table 114. BioSino Recent Development
Table 115. BSBE Company Information
Table 116. BSBE Business Overview
Table 117. BSBE In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. BSBE In-Vitro Diagnostics Product Portfolio
Table 119. BSBE Recent Development
Table 120. Maccura Company Information
Table 121. Maccura Business Overview
Table 122. Maccura In-Vitro Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Maccura In-Vitro Diagnostics Product Portfolio
Table 124. Maccura Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Authors List of This Report
Table 127. Secondary Sources
Table 128. Primary Sources
LIST OF FIGURES
Figure 1. In-Vitro Diagnostics Product Picture
Figure 2. Global In-Vitro Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global In-Vitro Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 4. Global In-Vitro Diagnostics Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Tissue Diagnostics Picture
Figure 8. Professional Diagnostic Picture
Figure 9. Molecular Diagnostic Picture
Figure 10. Diabetes Monitoring Picture
Figure 11. Other Picture
Figure 12. Global In-Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global In-Vitro Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 14. Global In-Vitro Diagnostics Sales Value Share by Type (2019-2030)
Figure 15. Diabetes Picture
Figure 16. Infectious Diseases Picture
Figure 17. Oncology Picture
Figure 18. Cardiology Picture
Figure 19. HIV Picture
Figure 20. Other Picture
Figure 21. Global In-Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global In-Vitro Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 23. Global In-Vitro Diagnostics Sales Value Share by Application (2019-2030)
Figure 24. Global In-Vitro Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 25. Global In-Vitro Diagnostics Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 26. North America In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. North America In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Europe In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 30. Asia-Pacific In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Latin America In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 33. Latin America In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 36. USA In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. USA In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. USA In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. Canada In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. Canada In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. Canada In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. Germany In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. Germany In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. Germany In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. France In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. France In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. France In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. U.K. In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. U.K. In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. U.K. In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Italy In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Italy In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Italy In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Netherlands In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Netherlands In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Netherlands In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Nordic Countries In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Nordic Countries In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Nordic Countries In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. China In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. China In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. China In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Japan In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Japan In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Japan In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. South Korea In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. South Korea In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. South Korea In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Southeast Asia In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Southeast Asia In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Southeast Asia In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. India In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. India In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. India In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Australia In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Australia In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Australia In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Mexico In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Mexico In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Mexico In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Brazil In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Brazil In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Brazil In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Turkey In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Turkey In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Turkey In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Saudi Arabia In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Saudi Arabia In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Saudi Arabia In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. UAE In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. UAE In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. UAE In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. Years Considered
Figure 94. Research Process
Figure 95. Key Executives Interviewed
Figure 1. In-Vitro Diagnostics Product Picture
Figure 2. Global In-Vitro Diagnostics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global In-Vitro Diagnostics Market Size (2019-2030) & (US$ Million)
Figure 4. Global In-Vitro Diagnostics Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Tissue Diagnostics Picture
Figure 8. Professional Diagnostic Picture
Figure 9. Molecular Diagnostic Picture
Figure 10. Diabetes Monitoring Picture
Figure 11. Other Picture
Figure 12. Global In-Vitro Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global In-Vitro Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 14. Global In-Vitro Diagnostics Sales Value Share by Type (2019-2030)
Figure 15. Diabetes Picture
Figure 16. Infectious Diseases Picture
Figure 17. Oncology Picture
Figure 18. Cardiology Picture
Figure 19. HIV Picture
Figure 20. Other Picture
Figure 21. Global In-Vitro Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global In-Vitro Diagnostics Sales Value Share 2019 VS 2023 VS 2030
Figure 23. Global In-Vitro Diagnostics Sales Value Share by Application (2019-2030)
Figure 24. Global In-Vitro Diagnostics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 25. Global In-Vitro Diagnostics Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 26. North America In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 27. North America In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Europe In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 30. Asia-Pacific In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Latin America In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 33. Latin America In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa In-Vitro Diagnostics Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa In-Vitro Diagnostics Sales Value Share by Country (%), 2023 VS 2030
Figure 36. USA In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. USA In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. USA In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. Canada In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. Canada In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. Canada In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. Germany In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. Germany In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. Germany In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. France In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. France In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. France In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. U.K. In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. U.K. In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. U.K. In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Italy In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Italy In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Italy In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. Netherlands In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. Netherlands In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. Netherlands In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Nordic Countries In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Nordic Countries In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Nordic Countries In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. China In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. China In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. China In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Japan In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Japan In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Japan In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. South Korea In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. South Korea In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. South Korea In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Southeast Asia In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Southeast Asia In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Southeast Asia In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. India In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. India In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. India In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Australia In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Australia In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Australia In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Mexico In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Mexico In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Mexico In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Brazil In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Brazil In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Brazil In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Turkey In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Turkey In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Turkey In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Saudi Arabia In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Saudi Arabia In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Saudi Arabia In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. UAE In-Vitro Diagnostics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. UAE In-Vitro Diagnostics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. UAE In-Vitro Diagnostics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. Years Considered
Figure 94. Research Process
Figure 95. Key Executives Interviewed
